Clinical Trial: Translational research on rare earth-modified antibiotic bone cement promoting diabetic foot ulcer healing by regulating macrophage polarization via the PI3K/AKT/mTOR pathway (China)

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Translational research on rare earth-modified antibiotic bone cement promoting diabetic foot ulcer healing by regulating macrophage polarization via the PI3K/AKT/mTOR pathway'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130542

Registration Time: 2026/08/21

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334113

Published by HT Digital Content Services with permission from Health Daily Digest....